Evidence map›Paper›PMID 37304067›Full record

ReviewFrontiers in molecular biosciences2023

Casticin as potential anticancer agent: recent advancements in multi-mechanistic approaches.

Katya Carbone, Fabio Gervasi, Latipa Kozhamzharova, Nazgul Altybaeva, Eda Sönmez Gürer, Javad Sharifi-Rad, Christophe Hano, Daniela Calina

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in molecular biosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 6 countries.

Katya CarboneCREA-Research Centre for Olive, Fruit and Citrus Crops, Rome, Italy.
Fabio GervasiCREA-Research Centre for Olive, Fruit and Citrus Crops, Rome, Italy.
Latipa KozhamzharovaDepartment of Scientific Works and International Relations, International Taraz Innovative Institute Named After Sherkhan Murtaza, Taraz, Kazakhstan.
Nazgul AltybaevaDepartment of Molecular Biology and Genetics, Al-Farabi Kazakh National University, Al-frabi, Kazakhstan.
Eda Sönmez GürerDepartment of Pharmacognosy, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Türkiye.
Javad Sharifi-RadFacultad de Medicina, Universidad del Azuay, Cuenca, Ecuador.
Christophe HanoDepartment of Biological Chemistry, Université ď Orléans, Orléans, France.
Daniela CalinaDepartment of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Research Centre for Olive Growing and Olive Oil Industry · ITAl-Farabi Kazakh National University · KZSivas Cumhuriyet Üniversitesi · TRUniversidad del Azuay · ECUniversité d'Orléans · FRUniversity of Medicine and Pharmacy of Craiova · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plants, with their range of pharmacologically active molecules, represent the most promising source for the production of new anticancer drugs and for the formulation of adjuvants in chemotherapy treatments to reduce drug content and/or counteract the side effects of chemotherapy. Casticin is a major bioactive flavonoid isolated from several plants, mainly from the

Indexed as

apoptosiscancercasticinmolecular mechanismssignaling pathwaysVitex spp.

Identifiers

PMID37304067
PMCPMC10250667
OpenAlexW4378471629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.